Dr. Tal Zaks' Drive To Improve Patients' Lives
Source: Bioprocess Online
Exsilio Therapeutics’ CEO Tal Zaks was Moderna’s CMO during the creation of the COVID-19 vaccine, but he has also served patients as a physician, scientist, investor, and biotech builder.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
This website uses cookies to ensure you get the best experience on our website. Learn more